Postmenopausal Hormone Therapy as a Risk Factor for Gastroesophageal Reflux Symptoms Among Female Twins

Gastroenterology

Volumn 134, Issue 4, 2008, Pages 921-928

  Nordenstedt, Helena ^a   Zheng, Zongli ^a   Cameron, Alan J ^b   Ye, Weimin ^a   Pedersen, Nancy L ^a   Lagergren, Jesper ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; GESTAGEN; ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; ESTROGEN THERAPY; FEMALE; GASTROESOPHAGEAL REFLUX; HEREDITY; HORMONAL THERAPY; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; QUESTIONNAIRE; TELEPHONE; TWINS;

EID: 41349115892     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2008.01.009     Document Type: Article

References (44)

1. Nilsson M., Johnsen R., Ye W., et al. Prevalence of gastro-oesophageal reflux symptoms and the influence of age and sex. Scand J Gastroenterol 39 (2004) 1040-1045
2. Dent J., El-Serag H.B., Wallander M.A., et al. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 54 (2005) 710-717
3. Nebel O.T., Fornes M.F., and Castell D.O. Symptomatic gastroesophageal reflux: incidence and precipitating factors. Am J Dig Dis 21 (1976) 953-956
4. Locke III G.R., Talley N.J., Fett S.L., et al. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 112 (1997) 1448-1456
5. Revicki D.A., Wood M., Maton P.N., et al. The impact of gastroesophageal reflux disease on health-related quality of life. Am J Med 104 (1998) 252-258
6. Eloubeidi M.A., and Provenzale D. Health-related quality of life and severity of symptoms in patients with Barrett's esophagus and gastroesophageal reflux disease patients without Barrett's esophagus. Am J Gastroenterol 95 (2000) 1881-1887
7. Solaymani-Dodaran M., Logan R.F., West J., et al. Mortality associated with Barrett's esophagus and gastroesophageal reflux disease diagnoses-a population-based cohort study. Am J Gastroenterol 100 (2005) 2616-2621
8. Sandler R.S., Everhart J.E., Donowitz M., et al. The burden of selected digestive diseases in the United States. Gastroenterology 122 (2002) 1500-1511
9. Henke C.J., Levin T.R., Henning J.M., et al. Work loss costs due to peptic ulcer disease and gastroesophageal reflux disease in a health maintenance organization. Am J Gastroenterol 95 (2000) 788-792
10. Lagergren J., Bergstrom R., Lindgren A., et al. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 340 (1999) 825-831
11. In: Berrino F., Capocaccia R., Estève J., et al. (Eds). Survival of cancer patients in Europe: the EUROCARE Study II (1999), International Agency for Research on Cancer, Lyon, France IARC Scientific Publication No 151
12. Devesa S.S., Blot W.J., and Fraumeni Jr. J.F. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 83 (1998) 2049-2053
13. Cameron A.J., Lagergren J., Henriksson C., et al. Gastroesophageal reflux disease in monozygotic and dizygotic twins. Gastroenterology 122 (2002) 55-59
14. Nilsson M., Johnsen R., Ye W., et al. Obesity and estrogen as risk factors for gastroesophageal reflux symptoms. JAMA 290 (2003) 66-72
15. Corley D.A., and Kubo A. Body mass index and gastroesophageal reflux disease: a systematic review and meta-analysis. Am J Gastroenterol 101 (2006) 2619-2628
16. Jacobson B.C., Somers S.C., Fuchs C.S., et al. Body-mass index and symptoms of gastroesophageal reflux in women. N Engl J Med 354 (2006) 2340-2348
17. Hampel H., Abraham N.S., and El-Serag H.B. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med 143 (2005) 199-211
18. Locke III G.R., Talley N.J., Fett S.L., et al. Risk factors associated with symptoms of gastroesophageal reflux. Am J Med 106 (1999) 642-649
19. Nilsson M., Johnsen R., Ye W., et al. Lifestyle related risk factors in the aetiology of gastro-oesophageal reflux. Gut 53 (2004) 1730-1735
20. Mohammed I., Cherkas L.F., Riley S.A., et al. Genetic influences in gastro-oesophageal reflux disease: a twin study. Gut 52 (2003) 1085-1089
21. Nilsson M., Lundegardh G., Carling L., et al. Body mass and reflux oesophagitis: an oestrogen-dependent association?. Scand J Gastroenterol 37 (2002) 626-630
22. Lichtenstein P., De Faire U., Floderus B., et al. The Swedish Twin Registry: a unique resource for clinical, epidemiological and genetic studies. J Intern Med 252 (2002) 184-205
23. Vakil N., van Zanten S.V., Kahrilas P., et al. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 101 (2006) 1900-1920 quiz 1943
24. Lubin J.H., and Gail M.H. Biased selection of controls for case-control analyses of cohort studies. Biometrics 40 (1984) 63-75
25. Hawkes C.H. Twin studies in medicine-what do they tell us?. Q J Med 90 (1997) 311-321
26. Zeger S.L., and Liang K.Y. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 42 (1986) 121-130
27. WHO. Energy and protein requirements (1985), World Health Organization, Geneva, Switzerland 1-67 Report of a Joint FAO/WHO/UNU Expert Consultation. WHO Technical Report Series, Volume 724
28. Eslick G.D., Jones M.P., and Talley N.J. Non-cardiac chest pain: prevalence, risk factors, impact and consulting-a population-based study. Aliment Pharmacol Ther 17 (2003) 1115-1124
29. Klauser A.G., Schindlbeck N.E., and Muller-Lissner S.A. Symptoms in gastro-oesophageal reflux disease. Lancet 335 (1990) 205-208
30. Revicki D.A., Wood M., Wiklund I., et al. Reliability and validity of the Gastrointestinal Symptom Rating Scale in patients with gastroesophageal reflux disease. Qual Life Res 7 (1998) 75-83
31. Norell S.E., Boethius G., and Persson I. Oral contraceptive use: interview data versus pharmacy records. Int J Epidemiol 27 (1998) 1033-1037
32. Wilson P.W., Garrison R.J., and Castelli W.P. Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50. The Framingham Study. N Engl J Med 313 (1985) 1038-1043
33. Colditz G.A., Hankinson S.E., Hunter D.J., et al. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med 332 (1995) 1589-1593
34. Matthews K.A., Kuller L.H., Wing R.R., et al. Prior to use of estrogen replacement therapy, are users healthier than nonusers?. Am J Epidemiol 143 (1996) 971-978
35. Weiner C.P., Lizasoain I., Baylis S.A., et al. Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc Natl Acad Sci U S A 91 (1994) 5212-5216
36. Hirsch D.P., Holloway R.H., Tytgat G.N., et al. Involvement of nitric oxide in human transient lower esophageal sphincter relaxations and esophageal primary peristalsis. Gastroenterology 115 (1998) 1374-1380
37. Van Thiel D.H., Gavaler J.S., and Stremple J. Lower esophageal sphincter pressure in women using sequential oral contraceptives. Gastroenterology 71 (1976) 232-234
38. Richter J.E. Gastroesophageal reflux disease during pregnancy. Gastroenterol Clin North Am 32 (2003) 235-261
39. Olans L.B., and Wolf J.L. Gastroesophageal reflux in pregnancy. Gastrointest Endosc Clin North Am 4 (1994) 699-712
40. Torbey C.F., and Richter J.E. Gastrointestinal motility disorders in pregnancy. Semin Gastrointest Dis 6 (1995) 203-216
41. Van Thiel D.H., and Wald A. Evidence refuting a role for increased abdominal pressure in the pathogenesis of the heartburn associated with pregnancy. Am J Obstet Gynecol 140 (1981) 420-422
42. Fisher R.S., Roberts G.S., Grabowski C.J., et al. Altered lower esophageal sphincter function during early pregnancy. Gastroenterology 74 (1978) 1233-1237
43. Fisher R.S., Roberts G.S., Grabowski C.J., et al. Inhibition of lower esophageal sphincter circular muscle by female sex hormones. Am J Physiol 234 (1978) E243-E247
44. Lagergren J. Controversies surrounding body mass, reflux, and risk of oesophageal adenocarcinoma. Lancet Oncol 7 (2006) 347-349